Most investors know that the stock market has delivered solid results over time, beating returns for bonds and many other popular assets. Less obvious is that most of the long-term gains have been ...

Thinking about trading in 2026? Start now: build a rules-based plan, master risk per trade, track taxes, test strategies, ...

Say that you and a friend were having a discussion about how the stock market works in 1996. Robert Shiller had just delivered his testimony to the Federal Reserve, in which he argued that investors ...

An all-equity portfolio, with a focus on international stocks, could be the key to maximizing retirement wealth, research suggests. Forget 60/40. Goodbye, target-date funds. So long, bonds. An all ...

Investing has grown increasingly complex in recent decades, with hedge funds, commodities, real estate, private equities, foreign stocks and other assets thrown into a mix that traditionally was ...

Last week, the U.S. Supreme Court heard a case debating whether it's legal to restrict content moderation on social media platforms like Facebook, YouTube and X. Those companies should anticipate a ...

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is among the hidden multibagger stocks to invest in. It reported positive results from the registrational cohort of the EMBOLD study 4.

Athira Pharma, Inc ATHA recently announced that it has dosed the last patient in the phase II/III LIFT-AD study, which is evaluating its pipeline candidate, fosgonimeton for the treatment of ...

Shares of Amylyx Pharmaceuticals AMLX nosedived 82.2% on Mar 8 after management announced topline results from the phase III PHOENIX study evaluating Relyvrio (AMX0035) for the treatment of ...

CervoMed's stock surged more than 400% after interim data showed significant improvement with a new batch of neflamapimod in treating Dementia with Lewy Bodies. The recent interim readout deserves ...